SEC Form 4 · accession 0001140361-19-002484
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent Kelton
Officer — Chief Executive Officer
Period of report
Feb 5, 2019
Accepted (ET)
Feb 5, 2019 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 5, 2019 | J | 986,777 | — | A | 1,079,953 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares issued to the Reporting Person by the Issuer as payment of an earn-out in connection with the Issuer's acquisition of a wholly-owned subsidiary in March 2017, of which the Reporting Person had been an employee and shareholder.